Tech Company Financing Transactions
PowderJect Pharmaceuticals PLC Funding Round
PowderJect Pharmaceuticals PLC, based in Oxford, secured $34.5 million from SV Health Investors, Abingworth and Oxford Bioscience Partners.
Transaction Overview
Company Name
Announced On
5/17/2004
Transaction Type
Venture Equity
Amount
$34,500,000
Round
Series A
Investors
Proceeds Purpose
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
4 Robert Robinson Avenue The Oxford Science Park
Oxford, OX4 4GA
UK
Oxford, OX4 4GA
UK
Phone
Website
Email Address
Not Recorded
Overview
PowderMed is an immunotherapeutic product company located in Oxford, UK. We have six lead programmes targeting influenza, chronic viral diseases and cancer. These products are all based on our proprietary DNA particle mediated epidermal delivery (PMED) technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Clive Dix
Browse more venture capital transactions:
Prev: 5/17/2004: Softricity venture capital transaction
Next: 5/17/2004: Olista venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs